Jane E. Wilcox
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jane E. Wilcox has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Rebecca Harap
Northwestern University
8 shared publications - Tingqing Wu
Northwestern University, Chicago, IL (K.L.G., T.W., D.T.P.).
6 shared publications - Sadiya Sana Khan
Northwestern University Feinberg School of Medicine
5 shared publications - Anjan Tibrewala
Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
4 shared publications - Pham Duc Thinh
Northwestern University Feinberg School of Medicine
4 shared publications - Anthony V. Pensa
Northwestern University Feinberg School of Medicine, Chicago, Illinois, US
3 shared publications
Latest Publications
- 9 November 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Learning to Live With a Ventricular Assist Device: Patient, Caregiver, and Clinician Concerns Following Implantation and Hospital Discharge
Patients undergoing ventricular assist device (VAD) implantation and their caregivers must attain knowledge and skills to perform VAD self-care safely. Little is known about the similarities and differences among patients, caregivers, and VAD clinicians related to VAD self-care training and management. This study explored the perspectives of 15 VAD patients, 12 VAD caregivers, and 18 VAD clinicians through individual semi-structured interviews focused on understanding barriers related to VAD self-care training and concerns about VAD self-care post-discharge. We identified four major themes (training related, care transitions, fear and uncertainty, clinical consequences). All participant groups discussed concerns related to daily VAD self-care and the transition home after implantation. Caregivers and clinicians discussed the steep VAD self-care learning curve. Caregivers and patients discussed fears in general ( eg , constant fear) and specific terms ( eg , VAD malfunction), whereas clinicians who discussed fear/uncertainty identified strategies for dealing with emergent situations. Concerns regarding adverse events and non-adherence arose primarily from clinicians. Although some alignment was found, concerns varied among stakeholders. A common understanding of these nuanced concerns may improve VAD self-care training and the preparation of patients and caregivers.
- 9 November 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Learning to Live With a Ventricular Assist Device: Patient, Caregiver, and Clinician Concerns Following Implantation and Hospital Discharge
Patients undergoing ventricular assist device (VAD) implantation and their caregivers must attain knowledge and skills to perform VAD self-care safely. Little is known about the similarities and differences among patients, caregivers, and VAD clinicians related to VAD self-care training and management. This study explored the perspectives of 15 VAD patients, 12 VAD caregivers, and 18 VAD clinicians through individual semi-structured interviews focused on understanding barriers related to VAD self-care training and concerns about VAD self-care post-discharge. We identified four major themes (training related, care transitions, fear and uncertainty, clinical consequences). All participant groups discussed concerns related to daily VAD self-care and the transition home after implantation. Caregivers and clinicians discussed the steep VAD self-care learning curve. Caregivers and patients discussed fears in general ( eg , constant fear) and specific terms ( eg , VAD malfunction), whereas clinicians who discussed fear/uncertainty identified strategies for dealing with emergent situations. Concerns regarding adverse events and non-adherence arose primarily from clinicians. Although some alignment was found, concerns varied among stakeholders. A common understanding of these nuanced concerns may improve VAD self-care training and the preparation of patients and caregivers.
- 1 April 2026
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 32 (6) , 1111-1115
Comparison of Inpatient End-of-Life Care Intensity Between Heart Failure and Cancer
- 1 April 2026
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 32 (6) , 1111-1115
Comparison of Inpatient End-of-Life Care Intensity Between Heart Failure and Cancer
- Open Access
- 24 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7554
Effect of Concomitant Tricuspid Valve Repair on Clinical and Echocardiographic Outcomes in Patients Undergoing Left Ventricular Assist Device Implantation
Objectives: The purpose of this study was to determine whether concomitant tricuspid valve repair (TVr) at the time of left ventricular assist device (LVAD) implantation improves outcomes in patients with ≥moderate tricuspid regurgitation (TR) and to evaluate the prognostic value of preoperative right ventricular (RV) strain. Methods: In a retrospective analysis of 100 LVAD recipients (44 TVr; 56 No-TVr), preoperative (preop) and postoperative (postop) clinical, echocardiographic, and hemodynamic variables, including pulmonary vascular resistance (PVR) and pulmonary artery pulsatility index (PAPI), were analyzed. RV free wall strain (RV-FWS) and RV fractional area change (RV-FAC) were measured by speckle tracking. Early right heart failure (RHF) was modeled with multivariable logistic regression, and 2-year mortality was assessed with Fine–Gray competing risk regression. Preoperative and three-month measurements were compared within each of the 100 patients. Results: Baseline invasive hemodynamics, RV-FWS, and RV-FAC were similar between the TVr and No-TVr groups. TVr at the time of LVAD implantation reduced postoperative TR grade, but it did not improve RV-FWS or RV-FAC at 3 months. The No-TVr patients were more often discharged home and had lower 30-day readmissions. PVR was comparable preoperatively and at 3 months postoperatively. In adjusted analyses, preop PVR, PAPI, and TVr were not independently associated with early RHF, whereas decreased preoperative RV-FWS and lower preop RV-FAC independently predicted higher 2-year mortality. Conclusions: In LVAD recipients with ≥moderate TR, concomitant TVr lowers postoperative TR severity but does not improve early RHF, RV strain-based remodeling, or 2-year mortality. Preoperative RV deformation metrics, rather than preoperative PVR or PAPI, independently predict survival following LVAD implantation with or without TVr.
- 24 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7554
Open AccessEffect of Concomitant Tricuspid Valve Repair on Clinical and Echocardiographic Outcomes in Patients Undergoing Left Ventricular Assist Device Implantation
Objectives: The purpose of this study was to determine whether concomitant tricuspid valve repair (TVr) at the time of left ventricular assist device (LVAD) implantation improves outcomes in patients with ≥moderate tricuspid regurgitation (TR) and to evaluate the prognostic value of preoperative right ventricular (RV) strain. Methods: In a retrospective analysis of 100 LVAD recipients (44 TVr; 56 No-TVr), preoperative (preop) and postoperative (postop) clinical, echocardiographic, and hemodynamic variables, including pulmonary vascular resistance (PVR) and pulmonary artery pulsatility index (PAPI), were analyzed. RV free wall strain (RV-FWS) and RV fractional area change (RV-FAC) were measured by speckle tracking. Early right heart failure (RHF) was modeled with multivariable logistic regression, and 2-year mortality was assessed with Fine–Gray competing risk regression. Preoperative and three-month measurements were compared within each of the 100 patients. Results: Baseline invasive hemodynamics, RV-FWS, and RV-FAC were similar between the TVr and No-TVr groups. TVr at the time of LVAD implantation reduced postoperative TR grade, but it did not improve RV-FWS or RV-FAC at 3 months. The No-TVr patients were more often discharged home and had lower 30-day readmissions. PVR was comparable preoperatively and at 3 months postoperatively. In adjusted analyses, preop PVR, PAPI, and TVr were not independently associated with early RHF, whereas decreased preoperative RV-FWS and lower preop RV-FAC independently predicted higher 2-year mortality. Conclusions: In LVAD recipients with ≥moderate TR, concomitant TVr lowers postoperative TR severity but does not improve early RHF, RV strain-based remodeling, or 2-year mortality. Preoperative RV deformation metrics, rather than preoperative PVR or PAPI, independently predict survival following LVAD implantation with or without TVr.
- 1 February 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (2) , e240142
Cardiac MRI in Heart Transplantation: Approaches and Clinical Insights
Cardiac MRI provides comprehensive insights into orthotopic heart transplant (OHT) allograft structure and function with advanced tissue characterization and quantitative myocardial perfusion techniques and can be considered a complementary noninvasive tool for investigation and monitoring of major complications that limit the durability of OHT.
- 1 February 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (2) , e240142
Cardiac MRI in Heart Transplantation: Approaches and Clinical Insights
Cardiac MRI provides comprehensive insights into orthotopic heart transplant (OHT) allograft structure and function with advanced tissue characterization and quantitative myocardial perfusion techniques and can be considered a complementary noninvasive tool for investigation and monitoring of major complications that limit the durability of OHT.
- Open Access
- 26 December 2024
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 20 (1) , 125-127
Cardiac Recovery: Webcast September 24 2024
This 61-minute webcast features a conversation about “Cardiac Recovery”—the focus of Issue 20.4. Led by the issue’s editors, the discussion engages the authors on emerging themes and lessons learned while researching and writing the articles. View the video at https://vimeo.com/event/4490511.
- 26 December 2024
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 20 (1) , 125-127
Open AccessCardiac Recovery: Webcast September 24 2024
This 61-minute webcast features a conversation about “Cardiac Recovery”—the focus of Issue 20.4. Led by the issue’s editors, the discussion engages the authors on emerging themes and lessons learned while researching and writing the articles. View the video at https://vimeo.com/event/4490511.
- Open Access
- 20 August 2024
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 20 (4) , 6-15
Clinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance
Partial or complete imaging resolution of left ventricular (LV) systolic dysfunction in patients with heart failure with reduced ejection fraction (HFrEF) has gone by many names in the past few decades, including LV recovery, remission, reverse remodeling, and, most recently, improvement. This phenomenon has been described in a variety of clinical scenarios, including removal of an acute myocardial insult, unloading with durable LV assist devices, and treatment with various devices as well as pharmacotherapies, termed guideline-directed medical therapy (GDMT). Irrespective of definition, systolic improvement is associated with improved clinical outcomes compared to persistent systolic dysfunction. In the past few years, systolic improvement has been distinguished from HFrEF as a new clinical entity referred to as HF with improved EF (HFimpEF). Given the relative novelty of this condition, there is a paucity of data with regard to the clinical trajectory and management of this population. In this review, we describe the history of myocardial improvement terminology and explore notable findings that have led to the delineation of HFimpEF. Additionally, we highlight the importance of understanding LV trajectory and the potential opportunity for new GDMT management for clinicians when treating patients with HFimpEF.
- 20 August 2024
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 20 (4) , 6-15
Open AccessClinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance
Partial or complete imaging resolution of left ventricular (LV) systolic dysfunction in patients with heart failure with reduced ejection fraction (HFrEF) has gone by many names in the past few decades, including LV recovery, remission, reverse remodeling, and, most recently, improvement. This phenomenon has been described in a variety of clinical scenarios, including removal of an acute myocardial insult, unloading with durable LV assist devices, and treatment with various devices as well as pharmacotherapies, termed guideline-directed medical therapy (GDMT). Irrespective of definition, systolic improvement is associated with improved clinical outcomes compared to persistent systolic dysfunction. In the past few years, systolic improvement has been distinguished from HFrEF as a new clinical entity referred to as HF with improved EF (HFimpEF). Given the relative novelty of this condition, there is a paucity of data with regard to the clinical trajectory and management of this population. In this review, we describe the history of myocardial improvement terminology and explore notable findings that have led to the delineation of HFimpEF. Additionally, we highlight the importance of understanding LV trajectory and the potential opportunity for new GDMT management for clinicians when treating patients with HFimpEF.
- 20 January 2024
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 82, 102-112
Heart failure with improved ejection fraction: Beyond diagnosis to trajectory analysis
- 20 January 2024
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 82, 102-112
Heart failure with improved ejection fraction: Beyond diagnosis to trajectory analysis
- 12 April 2023
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 29 (4) , 611-612
Cardiac Transplantation With Increased-risk Donors: Trends And Clinical Outcomes
- 12 April 2023
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 29 (4) , 611-612
Cardiac Transplantation With Increased-risk Donors: Trends And Clinical Outcomes
- 2 January 2023
- Published by Elsevier in JACC: Heart Failure
- Vol. 11 (1) , 55-57
Personalizing Risk Assessment for Sudden Cardiac Death in Heart Failure
- 2 January 2023
- Published by Elsevier in JACC: Heart Failure
- Vol. 11 (1) , 55-57
Personalizing Risk Assessment for Sudden Cardiac Death in Heart Failure